Acadian Asset Management Has Boosted Its Forestar Group (FOR) Stake; Natus Medical Has 1.17 Sentiment

September 9, 2017 - By Michael Collier

Acadian Asset Management Llc increased Forestar Group Inc (FOR) stake by 752.12% reported in 2016Q4 SEC filing. Acadian Asset Management Llc acquired 384,471 shares as Forestar Group Inc (FOR)’s stock rose 8.43%. The Acadian Asset Management Llc holds 435,589 shares with $5.79M value, up from 51,118 last quarter. Forestar Group Inc now has $725.47M valuation. It closed at $17.3 lastly. It is up 26.00% since September 9, 2016 and is uptrending. It has outperformed by 9.30% the S&P500.

Natus Medical Incorporated is a provider of newborn care and neurology healthcare services and products used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The company has market cap of $1.06 billion. The Company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It has a 57.76 P/E ratio.

Acadian Asset Management Llc decreased Echostar Corp (NASDAQ:SATS) stake by 20,149 shares to 158 valued at $8,000 in 2016Q4. It also reduced Republic Svcs Inc (NYSE:RSG) stake by 124,670 shares and now owns 1.84 million shares. Vodafone Group Plc New (NASDAQ:VOD) was reduced too.

Lyon Street Capital Llc holds 8.11% of its portfolio in Natus Medical Inc for 456,016 shares. Motley Fool Asset Management Llc owns 375,741 shares or 2.9% of their US portfolio. Moreover, Beddow Capital Management Inc has 2.57% invested in the company for 185,390 shares. The Delaware-based Ashford Capital Management Inc has invested 1.94% in the stock. Sio Capital Management Llc, a New York-based fund reported 90,865 shares.

The stock decreased 0.45% or $0.15 on September 8, reaching $32.9. About 310,629 shares traded. Natus Medical Inc (BABY) has risen 4.38% since September 9, 2016 and is uptrending. It has underperformed by 12.32% the S&P500.

Ratings analysis reveals 100% of Natus Medical’s analysts are positive. Out of 2 Wall Street analysts rating Natus Medical, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. BABY was included in 2 notes of analysts from September 13, 2016. Benchmark initiated the stock with “Buy” rating in Tuesday, October 4 report. The firm earned “Outperform” rating on Tuesday, September 13 by Raymond James.